Company profile: Convergence CT
1.1 - Company Overview
Company description
- Provider of health informatics solutions, including online portals, data networks, and analytics for healthcare providers. Offers the Revalo Health Platform for secure federated queries of de-identified data across hospitals, the Connected Technologies Platform to manage access and stage data, medical research services, EMR/EHR systems, and real-world evidence data from Asia for life sciences companies.
Products and services
- Connected Technologies Platform: Manages secure access to de-identified datasets and stages data locally at each participant site to enable federated queries across distributed healthcare networks
- Revalo Health Platform: A portal offering access to de-identified data from multiple hospitals and health systems through a secure federated query system
- Medical Research Service: Delivers services supporting the design, review, editing, statistical analysis, and publication of medical research for healthcare studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Convergence CT
GenoLogics
HQ: Canada
Website
- Description: Provider of discovery and biomedical solutions and collaborative data management software for life sciences research, deployable across multiple labs to support translational medicine and systems biology, advancing early detection, prevention, and treatment of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoLogics company profile →
Clinerion
HQ: Switzerland
Website
- Description: Provider of real-world data solutions analyzing live electronic health record data from a global network of partner hospitals to accelerate clinical research and access to treatments. Offerings include Patient Network Explorer for clinical research, trial optimization, and analytics; Feasibility Insights for site feasibility and trial planning; and RWD RADAR delivering aggregated de-identified data for epidemiology, treatment metrics, and market insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinerion company profile →
Deepcell
HQ: United States
Website
- Description: Provider of AI-powered single-cell classification and isolation solutions for basic and translational research, offering the REM-I platform combining high-resolution imaging, AI, and morphology-based sorting; the Human Foundation Model for real-time cell characterization; the Axon Data Suite for cloud storage, visualization, and analysis; plus advanced microfluidics and deep learning foundation models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deepcell company profile →
123Compliance
HQ: United States
Website
- Description: Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 123Compliance company profile →
Within3
HQ: United States
Website
- Description: Provider of a SaaS virtual engagement and digital collaboration platform for life science companies to compliantly connect and engage physicians, nurses, payers, and patients in groups large or small; offerings include an Insights Management Platform, AI-powered virtual engagement applications for global stakeholder discussions, client success support, and data science services for disease community analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Within3 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Convergence CT
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Convergence CT
2.2 - Growth funds investing in similar companies to Convergence CT
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Convergence CT
4.2 - Public trading comparable groups for Convergence CT
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →